PDHA1 and Familial prostate cancer: In summary, our data have demonstrated forced deficiency of PDHA1 expression by KO in prostate cancer cells results in metabolic reprogramming towards higher glutaminolysis, a process being preferentially vulnerable to glutamine inhibitors.